text_1: 本 试验 共 纳入 了 1 , 672 例 参与者 ; 559 例 被 分配 接受 安慰剂 治疗 , 556 例 接受 50 mg ubrogepant 治疗 , 557 例 接受 100 mg ubrogepant 治疗 .
  
text_2: a total of 1672 participants were enrolled ; 559 were assigned to receive placebo , 556 to receive 50 mg of ubrogepant , and 557 to receive 100 mg of ubrogepant .
  